医学
移植物排斥
免疫抑制
角膜移植
角膜
眼科
角膜移植
外科
皮肤病科
免疫学
移植
作者
Sohini Mandal,Prafulla K. Maharana,Luci Kaweri,Mohamed Ibrahime Asif,Ritu Nagpal,Namrata Sharma
标识
DOI:10.4103/ijo.ijo_228_23
摘要
The management of an episode of corneal graft rejection (CGR) is primarily by corticosteroids. Immunomodulators are useful for long-term immunosuppression and in dealing with cases of high-risk (HR) corneal grafts. The classical signs of CGR following penetrating keratoplasty (PKP) include rejection line, anterior chamber (AC) reaction, and graft edema. However, these signs may be absent or subtle in cases of endothelial keratoplasty (EK). Prevention of an episode of graft rejection is of utmost importance as it can reduce the need for donor cornea significantly. In our previous article (IJO_2866_22), we had discussed about the immunopathogenesis of CGR. In this review article, we aim to discuss the various clinical aspects and management of CGR.
科研通智能强力驱动
Strongly Powered by AbleSci AI